stock
Scienture Holdings, Inc.
NASDAQ | SCNX
1.17
USD
0.00
(0.00%
)AT CLOSE (AS OF Aug 15, 2025)
$27M
MARKET CAP
-
P/E Ratio
-20.22
EPS
$10
52 Week High
$0.69
52 Week Low
TRADE & SERVICES
Sector
SCNX Chart
Recent Chart
Price Action
1D
Candles
Trade Smarter
Automate your trading workflow with powerful tools — built for serious traders.
SCNX Technicals
SCNX Earnings
Yearly Income Statement (As of Dec 31, 2024)
| Field | Value (USD) |
|---|---|
| Gross Profit | $6K |
| Total Revenue | $137K |
| Cost Of Revenue | $131K |
| Costof Goods And Services Sold | $131K |
| Operating Income | -$15M |
| Selling General And Administrative | $12M |
| Research And Development | $2.2M |
| Operating Expenses | $15M |
| Investment Income Net | - |
| Net Interest Income | -$1.2M |
| Interest Income | $135K |
| Interest Expense | $1.3M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $53K |
| Income Before Tax | -$19M |
| Income Tax Expense | -$534K |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$18M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$17M |
| Ebitda | -$17M |
| Net Income | $9.1M |
Revenue & Profitability
Earnings Performance
SCNX Financials
yearly Balance Sheet (As of Dec 31, 2024)
| Field | Value (USD) |
|---|---|
| Total Assets | $105M |
| Total Current Assets | $6.3M |
| Cash And Cash Equivalents At Carrying Value | $308K |
| Cash And Short Term Investments | $308K |
| Inventory | $0 |
| Current Net Receivables | $5.4M |
| Total Non Current Assets | $99M |
| Property Plant Equipment | - |
| Accumulated Depreciation Amortization Ppe | - |
| Intangible Assets | $76M |
| Intangible Assets Excluding Goodwill | $76M |
| Goodwill | $21M |
| Investments | - |
| Long Term Investments | - |
| Short Term Investments | - |
| Other Current Assets | $548K |
| Other Non Current Assets | - |
| Total Liabilities | $26M |
| Total Current Liabilities | $7.9M |
| Current Accounts Payable | $2.9M |
| Deferred Revenue | - |
| Current Debt | - |
| Short Term Debt | $2.8M |
| Total Non Current Liabilities | $18M |
| Capital Lease Obligations | $220K |
| Long Term Debt | $612K |
| Current Long Term Debt | $2.7M |
| Long Term Debt Noncurrent | - |
| Short Long Term Debt Total | $3.5M |
| Other Current Liabilities | $2.2M |
| Other Non Current Liabilities | $1.3M |
| Total Shareholder Equity | $79M |
| Treasury Stock | - |
| Retained Earnings | -$39M |
| Common Stock | $87 |
| Common Stock Shares Outstanding | $3.7M |
yearly Cash Flow (As of Dec 31, 2024)
| Field | Value (USD) |
|---|---|
| Operating Cashflow | -$14M |
| Payments For Operating Activities | - |
| Proceeds From Operating Activities | - |
| Change In Operating Liabilities | - |
| Change In Operating Assets | - |
| Depreciation Depletion And Amortization | $53K |
| Capital Expenditures | $0 |
| Change In Receivables | - |
| Change In Inventory | $968 |
| Profit Loss | - |
| Cashflow From Investment | $28M |
| Cashflow From Financing | -$13M |
| Proceeds From Repayments Of Short Term Debt | - |
| Payments For Repurchase Of Common Stock | - |
| Payments For Repurchase Of Equity | - |
| Payments For Repurchase Of Preferred Stock | - |
| Dividend Payout | $15M |
| Dividend Payout Common Stock | $15M |
| Dividend Payout Preferred Stock | - |
| Proceeds From Issuance Of Common Stock | - |
| Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
| Proceeds From Issuance Of Preferred Stock | - |
| Proceeds From Repurchase Of Equity | - |
| Proceeds From Sale Of Treasury Stock | - |
| Change In Cash And Cash Equivalents | - |
| Change In Exchange Rate | - |
| Net Income | -$19M |
yearly Income Statement (As of Dec 31, 2024)
| Field | Value (USD) |
|---|---|
| Gross Profit | $6K |
| Total Revenue | $137K |
| Cost Of Revenue | $131K |
| Costof Goods And Services Sold | $131K |
| Operating Income | -$15M |
| Selling General And Administrative | $12M |
| Research And Development | $2.2M |
| Operating Expenses | $15M |
| Investment Income Net | - |
| Net Interest Income | -$1.2M |
| Interest Income | $135K |
| Interest Expense | $1.3M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $53K |
| Income Before Tax | -$19M |
| Income Tax Expense | -$534K |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$18M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$17M |
| Ebitda | -$17M |
| Net Income | $9.1M |
Dividends
| Field | Value |
|---|---|
| Ex Dividend Date | 2024-07-19 |
| Declaration Date | 2024-07-09 |
| Record Date | 2024-07-19 |
| Payment Date | 2024-07-24 |
| Amount | 1.5 |
SCNX News
SCNX Profile
Scienture Holdings, Inc. Profile
Sector: TRADE & SERVICES
Industry: WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES
None
Discover more tools and features to empower your trading
Explore FeaturesMarket data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.